• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃食管结合部 Siewert II 型腺癌转移患者的生存列线图:一项基于人群的研究。

Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, China.

Department of Urology, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, China.

出版信息

Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):757-764. doi: 10.1080/17474124.2020.1784726. Epub 2020 Jun 30.

DOI:10.1080/17474124.2020.1784726
PMID:32552040
Abstract

BACKGROUND

The aim of this study was to construct a nomogram to predict the survival of patients with metastatic Siewert Type II adenocarcinomas of the esophagogastric junction (AEG).

METHODS

Patients were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Cox regression analysis was performed to assess the prognostic factors. A nomogram comprising independent prognostic factors was established and evaluated using C-indexes, calibration curves, and decision curve analyses.

RESULTS

In total 1616 eligible patients were enrolled. Race, age, bone metastasis, liver metastasis, lung metastasis, other metastasis sites, and distant lymph nodes metastasis were independent prognostic factors and were integrated to construct the nomogram. The nomogram had a C-index of 0.590 (95% CI: 0.569-0.611) in the training cohort and 0.569 (95% CI: 0.532-0.606) in the validation cohort. The calibration plots for the probabilities of 6-month and 1-year overall survival demonstrated there was an optimum between nomogram prediction and actual observation.

CONCLUSION

We developed and validated a nomogram to predict individual prognosis for patients with metastatic Siewert Type II AEG, and the risk stratification system based on the nomogram could effectively stratify the patients into two risk subgroups, which can help clinicians accurately predict mortality risk and recommend personalized treatment modalities.

摘要

背景

本研究旨在构建一个列线图,以预测食管胃结合部(AEG)Ⅱ型 Siewert 型腺癌转移患者的生存情况。

方法

使用监测、流行病学和最终结果(SEER)数据库来识别患者。使用 Cox 回归分析来评估预后因素。基于独立的预后因素,建立并评估了一个列线图,通过 C 指数、校准曲线和决策曲线分析进行评估。

结果

共纳入 1616 名符合条件的患者。种族、年龄、骨转移、肝转移、肺转移、其他转移部位和远处淋巴结转移是独立的预后因素,并被整合到列线图中。该列线图在训练队列中的 C 指数为 0.590(95%CI:0.569-0.611),在验证队列中的 C 指数为 0.569(95%CI:0.532-0.606)。6 个月和 1 年总生存率的校准图表明,列线图预测与实际观察之间存在最佳契合度。

结论

我们开发并验证了一个用于预测转移性 Siewert Ⅱ型 AEG 患者个体预后的列线图,基于该列线图的风险分层系统可以有效地将患者分为两个风险亚组,这有助于临床医生准确预测死亡率风险,并推荐个性化的治疗方式。

相似文献

1
Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.胃食管结合部 Siewert II 型腺癌转移患者的生存列线图:一项基于人群的研究。
Expert Rev Gastroenterol Hepatol. 2020 Aug;14(8):757-764. doi: 10.1080/17474124.2020.1784726. Epub 2020 Jun 30.
2
Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.基于真实世界数据的食管胃结合部 Siewert Ⅱ/Ⅲ型腺癌患者生存列线图的建立和验证。
BMC Cancer. 2021 May 10;21(1):532. doi: 10.1186/s12885-021-08249-x.
3
Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.远处转移部位与 Siewert Ⅱ型食管胃结合部腺癌患者的肿瘤特异性生存:一项基于人群的研究。
Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):491-497. doi: 10.1080/17474124.2020.1760839. Epub 2020 Apr 29.
4
Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.术前放疗后预测食管胃交界部 Siewert Ⅱ型腺癌患者生存的列线图的建立
Ann Surg Oncol. 2019 May;26(5):1292-1300. doi: 10.1245/s10434-019-07237-7. Epub 2019 Feb 25.
5
Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.列线图预测食管胃交界腺癌患者的生存率。
World J Surg Oncol. 2015 Jun 10;13:197. doi: 10.1186/s12957-015-0613-7.
6
Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.不明原发灶转移性腺癌的肿瘤部位起源的危险因素和预测因素。
Cancer Med. 2021 Feb;10(3):974-988. doi: 10.1002/cam4.3684. Epub 2021 Jan 6.
7
The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.食管癌患者脑转移的风险和预后因素:SEER 数据库分析。
BMC Cancer. 2021 Sep 26;21(1):1057. doi: 10.1186/s12885-021-08802-8.
8
Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.食管胃交界部Siewert II型腺癌患者接受和未接受新辅助放疗的预后列线图:一项回顾性队列研究
Am J Transl Res. 2022 Jan 15;14(1):135-149. eCollection 2022.
9
Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.胃食管结合部 Siewert II T1 型腺癌淋巴结转移的预测因素:一项基于人群的研究。
Cancer Control. 2021 Jan-Dec;28:10732748211026668. doi: 10.1177/10732748211026668.
10
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.

引用本文的文献

1
Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis.Siewert II型食管胃交界腺癌列线图的开发与验证:一项回顾性分析
Ther Adv Med Oncol. 2024 Feb 4;16:17588359241229425. doi: 10.1177/17588359241229425. eCollection 2024.
2
Neural network-based prognostic predictive tool for gastric cardiac cancer: the worldwide retrospective study.基于神经网络的贲门癌预后预测工具:全球回顾性研究
BioData Min. 2023 Jul 18;16(1):21. doi: 10.1186/s13040-023-00335-z.
3
Nomogram for predicting the likelihood of liver metastases at initial diagnosis in patients with Siewert type II gastroesophageal junction adenocarcinoma.
预测 Siewert Ⅱ型胃食管结合部腺癌患者初始诊断时肝转移可能性的列线图。
Sci Rep. 2023 Jul 7;13(1):11032. doi: 10.1038/s41598-023-37318-3.
4
A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients.一种基于临床血液指标的新型列线图,用于预测接受根治性切除的食管胃交界腺癌患者的预后。
J Cancer. 2023 May 21;14(9):1553-1561. doi: 10.7150/jca.83588. eCollection 2023.
5
Clinical characteristics and prediction model of long time survival of patients with stage M1 Siewert type II esophagogastric junction adenocarcinoma.M1期Siewert II型食管胃交界腺癌患者长期生存的临床特征及预测模型
Transl Cancer Res. 2021 May;10(5):2002-2008. doi: 10.21037/tcr-20-3291.
6
Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study.食管胃交界腺癌的临床病理特征及生存预测:一项基于监测、流行病学和最终结果(SEER)数据库的回顾性研究
Int J Gen Med. 2021 Dec 24;14:10303-10314. doi: 10.2147/IJGM.S341405. eCollection 2021.
7
Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.胃食管结合部 Siewert II T1 型腺癌淋巴结转移的预测因素:一项基于人群的研究。
Cancer Control. 2021 Jan-Dec;28:10732748211026668. doi: 10.1177/10732748211026668.
8
Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.基于真实世界数据的食管胃结合部 Siewert Ⅱ/Ⅲ型腺癌患者生存列线图的建立和验证。
BMC Cancer. 2021 May 10;21(1):532. doi: 10.1186/s12885-021-08249-x.
9
Construction and Validation of a Convenient Clinical Nomogram to Predict the Risk of Brain Metastasis in Renal Cell Carcinoma Patients.构建并验证一种简便的临床列线图模型预测肾细胞癌患者发生脑转移的风险。
Biomed Res Int. 2020 Nov 17;2020:9501760. doi: 10.1155/2020/9501760. eCollection 2020.